Journal article
[The New WHO Guidelines for Rapid Diagnostics and Treatment of Drug-Resistant Tuberculosis Commented for Germany, Austria and Switzerland].
-
Otto-Knapp R
Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose e. V. (DZK), Berlin.
-
Knappik M
Klinik Penzing, Abteilung für Atemwegs- und Lungenkrankheiten, Wien.
-
Häcker B
Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose e. V. (DZK), Berlin.
-
Starzacher K
Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose e. V. (DZK), Berlin.
-
Bauer T
Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose e. V. (DZK), Berlin.
-
Lange C
Medizinische Klinik und FG Klinische Infektiologie, Forschungszentrum Borstel, Leibniz Lungenzentrum, Borstel.
-
Maurer FP
Nationales Referenzzentrum für Mykobakterien, Forschungszentrum Borstel, Leibniz Lungenzentrum, Borstel.
-
Schaberg T
Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose e. V. (DZK), Berlin.
-
Günther G
Universitätsklinik für Pneumologie, Inselspital, Universitätsspital Bern, Universität Bern, Schweiz.
Show more…
Published in:
- Pneumologie (Stuttgart, Germany). - 2020
English
The increasing evidence has made it necessary to change international recommendations for the diagnosis and treatment of resistant tuberculosis repeatedly in the recent years. This year, the WHO has published comprehensive recommendations that take into account these developments. The current German tuberculosis guideline was published in 2017 with differing recommendations in some areas. Here the new WHO recommendations of 2020 for rapid diagnosis and therapy of resistant tuberculosis are summarized and the relevant differences are commented for Germany, Austria and Switzerland. A complete re-evaluation of the literature is currently taking place by updating the German-language AWMF 2k guidelines.
-
Language
-
-
Open access status
-
closed
-
Identifiers
-
-
Persistent URL
-
https://sonar.ch/global/documents/414
Statistics
Document views: 55
File downloads: